Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 63 Enz. Inhib. hit(s) with all data for entry = 50026373
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM27725((2S)-2-[(3-{[(2-chloro-6-methylphenyl)carbamoyl]am...)
Affinity DataIC50:  80nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243599((S)-2-cyclohexyl-2-(2-(3-(2,6-dichlorophenyl)ureid...)
Affinity DataIC50:  100nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243678((S)-2-(2-(3-(2,6-dimethylphenyl)ureido)-2-naphtham...)
Affinity DataIC50:  120nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243601((S)-2-cyclohexyl-2-(2-(3-(2,6-dimethylphenyl)ureid...)
Affinity DataIC50:  120nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243677((S)-2-(2-(3-(2,6-dichlorophenyl)ureido)-2-naphtham...)
Affinity DataIC50:  230nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243352((S)-2-((S)-carboxy(2-(3-(2-chloro-6-methylphenyl)u...)
Affinity DataIC50:  270nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243353((2S,3S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2...)
Affinity DataIC50:  280nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243599((S)-2-cyclohexyl-2-(2-(3-(2,6-dichlorophenyl)ureid...)
Affinity DataIC50:  320nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243354((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  360nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243399((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  390nMAssay Description:Inhibition of human glycogen phosphorylase alpha in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243399((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  390nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243400((S)-4-amino-2-(2-(3-(2-chloro-6-methylphenyl)ureid...)
Affinity DataIC50:  420nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243401((2S,3R)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2...)
Affinity DataIC50:  430nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243402((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  450nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243444((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  520nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243445(2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-naphtha...)
Affinity DataIC50:  570nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243446((S)-1-((S)-carboxy(2-(3-(2-chloro-6-methylphenyl)u...)
Affinity DataIC50:  580nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243640((S)-2-cyclohexyl-2-(2-(3-(2,6-diethylphenyl)ureido...)
Affinity DataIC50:  590nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM27725((2S)-2-[(3-{[(2-chloro-6-methylphenyl)carbamoyl]am...)
Affinity DataIC50:  600nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243447((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  600nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243677((S)-2-(2-(3-(2,6-dichlorophenyl)ureido)-2-naphtham...)
Affinity DataIC50:  640nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243306((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  700nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243548((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-4,5-d...)
Affinity DataIC50:  860nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243353((2S,3S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2...)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243601((S)-2-cyclohexyl-2-(2-(3-(2,6-dimethylphenyl)ureid...)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243678((S)-2-(2-(3-(2,6-dimethylphenyl)ureido)-2-naphtham...)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243680((S)-2-(2-(3-o-tolylureido)-2-naphthamido)succinic ...)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243488((S)-5-amino-2-(2-(3-(2-chloro-6-methylphenyl)ureid...)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243399((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in absence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50242847((S)-2-(2-(3-(2-chlorophenyl)ureido)-2-naphthamido)...)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243600((S)-2-cyclohexyl-2-(2-(2-(2,6-dichlorophenyl)aceta...)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243354((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243401((2S,3R)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2...)
Affinity DataIC50:  1.90E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243305((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  2.20E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243305((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  2.20E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in presence of glucoseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243352((S)-2-((S)-carboxy(2-(3-(2-chloro-6-methylphenyl)u...)
Affinity DataIC50:  2.50E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243446((S)-1-((S)-carboxy(2-(3-(2-chloro-6-methylphenyl)u...)
Affinity DataIC50:  2.90E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243489((S)-6-amino-2-(2-(3-(2-chloro-6-methylphenyl)ureid...)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243402((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243447((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  3.30E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243351((R)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  4.20E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243640((S)-2-cyclohexyl-2-(2-(3-(2,6-diethylphenyl)ureido...)
Affinity DataIC50:  4.50E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243399((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-2-nap...)
Affinity DataIC50:  4.70E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243641((S)-2-cyclohexyl-2-(2-(3-(2,6-difluorophenyl)ureid...)
Affinity DataIC50:  4.90E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243679((S)-2-(2-(3-(2,6-difluorophenyl)ureido)-2-naphtham...)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243642((S)-2-cyclohexyl-2-(2-(3-o-tolylureido)-2-naphtham...)
Affinity DataIC50: >5.00E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243548((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-4,5-d...)
Affinity DataIC50:  6.80E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243600((S)-2-cyclohexyl-2-(2-(2-(2,6-dichlorophenyl)aceta...)
Affinity DataIC50:  6.80E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243491((S)-2-(2-(3-(2-chloro-6-methylphenyl)ureido)-4,5-d...)
Affinity DataIC50:  7.00E+3nMAssay Description:Inhibition of human glycogen phosphorylase alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50243400((S)-4-amino-2-(2-(3-(2-chloro-6-methylphenyl)ureid...)
Affinity DataIC50:  7.40E+3nMAssay Description:Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: